TY - JOUR
T1 - Parkinsonian daytime sleep-wake classification using deep brain stimulation lead recordings
AU - Verma, Ajay K.
AU - Yu, Ying
AU - Acosta-Lenis, Sergio F.
AU - Havel, Tyler
AU - Sanabria, David Escobar
AU - Molnar, Gregory F.
AU - MacKinnon, Colum D.
AU - Howell, Michael J.
AU - Vitek, Jerrold L.
AU - Johnson, Luke A.
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Excessive daytime sleepiness is a recognized non-motor symptom that adversely impacts the quality of life of people with Parkinson's disease (PD), yet effective treatment options remain limited. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for PD motor signs. Reliable daytime sleep-wake classification using local field potentials (LFPs) recorded from DBS leads implanted in STN can inform the development of closed-loop DBS approaches for prompt detection and disruption of sleep-related neural oscillations. We performed STN DBS lead recordings in three nonhuman primates rendered parkinsonian by administrating neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Reference sleep-wake states were determined on a second-by-second basis by video monitoring of eyes (eyes-open, wake and eyes-closed, sleep). The spectral power in delta (1–4 Hz), theta (4–8 Hz), low-beta (8–20 Hz), high-beta (20–35 Hz), gamma (35–90 Hz), and high-frequency (200–400 Hz) bands were extracted from each wake and sleep epochs for training (70% data) and testing (30% data) a support vector machines classifier for each subject independently. The spectral features yielded reasonable daytime sleep-wake classification (sensitivity: 90.68 ± 1.28; specificity: 88.16 ± 1.08; accuracy: 89.42 ± 0.68; positive predictive value; 88.70 ± 0.89, n = 3). Our findings support the plausibility of monitoring daytime sleep-wake states using DBS lead recordings. These results could have future clinical implications in informing the development of closed-loop DBS approaches for automatic detection and disruption of sleep-related neural oscillations in people with PD to promote wakefulness.
AB - Excessive daytime sleepiness is a recognized non-motor symptom that adversely impacts the quality of life of people with Parkinson's disease (PD), yet effective treatment options remain limited. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for PD motor signs. Reliable daytime sleep-wake classification using local field potentials (LFPs) recorded from DBS leads implanted in STN can inform the development of closed-loop DBS approaches for prompt detection and disruption of sleep-related neural oscillations. We performed STN DBS lead recordings in three nonhuman primates rendered parkinsonian by administrating neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Reference sleep-wake states were determined on a second-by-second basis by video monitoring of eyes (eyes-open, wake and eyes-closed, sleep). The spectral power in delta (1–4 Hz), theta (4–8 Hz), low-beta (8–20 Hz), high-beta (20–35 Hz), gamma (35–90 Hz), and high-frequency (200–400 Hz) bands were extracted from each wake and sleep epochs for training (70% data) and testing (30% data) a support vector machines classifier for each subject independently. The spectral features yielded reasonable daytime sleep-wake classification (sensitivity: 90.68 ± 1.28; specificity: 88.16 ± 1.08; accuracy: 89.42 ± 0.68; positive predictive value; 88.70 ± 0.89, n = 3). Our findings support the plausibility of monitoring daytime sleep-wake states using DBS lead recordings. These results could have future clinical implications in informing the development of closed-loop DBS approaches for automatic detection and disruption of sleep-related neural oscillations in people with PD to promote wakefulness.
KW - Daytime sleepiness
KW - Deep brain stimulation
KW - MPTP
KW - Nonhuman Primates
KW - Parkinson's disease
KW - Sleep-wake disturbances
KW - Subthalamic nucleus
KW - Support vector machines
UR - http://www.scopus.com/inward/record.url?scp=85144079702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144079702&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2022.105963
DO - 10.1016/j.nbd.2022.105963
M3 - Article
C2 - 36521781
AN - SCOPUS:85144079702
SN - 0969-9961
VL - 176
JO - Neurobiology of Disease
JF - Neurobiology of Disease
M1 - 105963
ER -